ANTIPODES PARTNERS Ltd: JNJ position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ANTIPODES PARTNERS Ltd on JNJ, newest first. How the timeline and the estimate are built.
ANTIPODES PARTNERS Ltd held 91,816 JNJ shares at 2026-06-30 per its 13F-HR filed 2026-08-06.
the latest 13F is the newest step
- period ended2026-06-3013F 91,816 sharesChange vs previous 13F -9,207 shares
0.43% of the 13F portfolio, value $23,318,510.
13F-HR 0001652442-26-000005 filed by ANTIPODES PARTNERS Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 101,023 sharesChange vs previous 13F -15,783 shares
0.48% of the 13F portfolio, value $24,694,062.
13F-HR 0001652442-26-000004 filed by ANTIPODES PARTNERS Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 116,806 sharesChange vs previous 13F -39,157 shares
0.51% of the 13F portfolio, value $24,174,814.
13F-HR 0001652442-26-000002 filed by ANTIPODES PARTNERS Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 155,963 sharesChange vs previous 13F +3,931 shares
0.65% of the 13F portfolio, value $28,920,841.
13F-HR 0001652442-25-000007 filed by ANTIPODES PARTNERS Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 152,032 sharesChange vs previous 13F not available
0.72% of the 13F portfolio, value $23,224,660.
13F-HR 0002005403-25-000004 filed by ANTIPODES PARTNERS Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).